Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia

by Aamer Aleem
Published 2009-04-01

Management of hematological malignancies during the COVID-19 pandemic

by Aamer Aleem, Mashael Altowairqi, Yazeed Bajuaifer, Musa Alzahrani
Published 2020-01-01

Optimal response to imatinib therapy in a case of chronic myeloid leukemia with a concurrent loss of distal 22q

by Bayan Alqahtany, Fatma S Alqahtani, Osamah Khojah, Abdurahman Almaeen, Aamer Aleem
Published 2017-01-01

Vanishing bile duct syndrome in a hodgkin′s lymphoma patient with fatal outcome despite lymphoma remission

by Aamer Aleem, Mohammad Al-Katari, Khalid Alsaleh, Khalid AlSwat, Abdulmalik Al-Sheikh
Published 2013-01-01

Management of adult immune thrombocytopenia: Recommendations by an expert Saudi panel

by Hazzaa Al-Zahrani, Aamer Aleem, Fahad Al Mohareb, Said Yousuf Ahmed, Ahmed M Al-Suliman, Hussain H Al Saeed, Mubarak S Al-Ghamdi, Hani Al-Hashmi
Published 2019-01-01

Eradication of prior-to-treatment compound BCR-ABL mutations by interferon-alpha in chronic myeloid leukemia: Long-term follow-up studies and review of literature

by Zafar Iqbal, Tanveer Akhtar, Ahmad M Khalid, Aamer Aleem, Amer Mahmood, Afia M Akram, Mahmood Rasool, Ijaz H Shah, Aysha Bhalli, Muhammad Khalid, Mudassar Iqbal, Abid Jameel, Nawaf Al-Anazi
Published 2020-01-01

Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib re...

by Zafar Iqbal, Aamer Aleem, Mudassar Iqbal, Mubashar Iqbal Naqvi, Ammara Gill, Abid Sohail Taj, Abdul Qayyum, Najeeb ur-Rehman, Ahmad Mukhtar Khalid, Ijaz Hussain Shah, Muhammad Khalid, Riazul Haq, Mahwish Khan, Shahid Mahmood Baig, Abid Jamil, Muhammad Naeem Abbas, Muhammad Absar, Amer Mahmood, Mahmood Rasool, Tanveer Akhtar
Published 2013-01-01